Cellectis (CLLS) Event Aug. 04, 2022, 20:39 UTC 15 1 comments (10% Negative) Cellectis (CLLS) Reports Q3 2022 Financial Results (Form 6-K) Comment Full text
Alector Inc (ALEC) Event Aug. 04, 2022, 20:33 UTC 25 1 comments (75% Positive) Alector, Inc. (ALEC) Announces Enrollment Update for submitted Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment Comment Full text
Generation Bio (GBIO) Event Aug. 04, 2022, 20:26 UTC 26 1 comments (98% Positive) Generation Bio Co. (GBIO) Reports Q3 2022 Financial Results Comment Full text
Coherus BioSciences Inc (CHRS) Event Aug. 04, 2022, 20:25 UTC 25 1 comments (30% Negative) COHERUS BIOSCIENCES, INC. (CHRS) Reports Q3 2022 Financial Results Comment Full text
Nektar Therapeutics (NKTR) Event Aug. 04, 2022, 20:23 UTC 23 1 comments (10% Negative) NEKTAR THERAPEUTICS (NKTR) Reports Q3 2022 Financial Results Comment Full text
Theravance Biopharma US Inc (TBPH) Event Aug. 04, 2022, 20:18 UTC 23 1 comments (19% Negative) THERAVANCE BIOPHARMA, INC. (TBPH) Reports Q3 2022 Financial Results Comment Full text
Legend Biotech (LEGN) Event Aug. 04, 2022, 20:18 UTC 24 1 comments (70% Positive) Legend Biotech (LEGN) Files Form 6-K Comment Full text
Akero Therapeutics (AKRO) Event Aug. 04, 2022, 20:17 UTC 22 1 comments (75% Positive) Akero Therapeutics, Inc. (AKRO) Announces Enrollment Update for results Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review Comment Full text
SIGA Technologies Inc (SIGA) Event Aug. 04, 2022, 20:16 UTC 23 1 comments (10% Negative) SIGA TECHNOLOGIES, INC. (SIGA) Reports Q3 2022 Financial Results Comment Full text
Protagonist Therapeutics Inc (PTGX) Event Aug. 04, 2022, 14:17 UTC 99 0 comments Protagonist Therapeutics, Inc - Corporate Presentation Comment Full text